Which approach of total hip arthroplasty is the best efficacy and least complication?

医学 随机对照试验 外科 梅德林 哈里斯髋关节评分 荟萃分析 并发症 关节置换术 内科学 政治学 法学
作者
Lertkong Nitiwarangkul,Natthapong Hongku,Oraluck Pattanaprateep,Sasivimol Rattanasiri,Patarawan Woratanarat,Ammarin Thakkinstian
出处
期刊:World journal of orthopedics [Springer Science+Business Media]
卷期号:15 (1): 73-93 被引量:1
标识
DOI:10.5312/wjo.v15.i1.73
摘要

BACKGROUND Total hip arthroplasty is as an effective intervention to relieve pain and improve hip function. Approaches of the hip have been exhaustively explored about pros and cons. The efficacy and the complications of hip approaches remains inconclusive. This study conducted an umbrella review to systematically appraise previous meta-analysis (MAs) including conventional posterior approach (PA), and minimally invasive surgeries as the lateral approach (LA), direct anterior approach (DAA), 2-incisions method, mini-lateral approach and the newest technique direct superior approach (DSA) or supercapsular percutaneously-assisted total hip (SuperPath). AIM To compare the efficacy and complications of hip approaches that have been published in all MAs and randomized controlled trials (RCTs). METHODS MAs were identified from MEDLINE and Scopus from inception until 2023. RCTs were then updated from the latest MA to September 2023. This study included studies which compared hip approaches and reported at least one outcome such as Harris Hip Score (HHS), dislocation, intra-operative fracture, wound complication, nerve injury, operative time, operative blood loss, length of hospital stay, incision length and VAS pain. Data were independently selected, extracted and assessed by two reviewers. Network MA and cluster rank and surface under the cumulative ranking curve (SUCRA) were estimated for treatment efficacy and safety. RESULTS Finally, twenty-eight MAs (40 RCTs), and 13 RCTs were retrieved. In total 47 RCTs were included for reanalysis. The results of corrected covered area showed high degree (13.80%). Among 47 RCTs, most of the studies were low risk of bias in part of random process and outcome reporting, while other domains were medium to high risk of bias. DAA significantly provided higher HHS at three months than PA [pooled unstandardized mean difference (USMD): 3.49, 95% confidence interval (CI): 0.98, 6.00 with SUCRA: 85.9], followed by DSA/SuperPath (USMD: 1.57, 95%CI: -1.55, 4.69 with SUCRA: 57.6). All approaches had indifferent dislocation and intraoperative fracture rates. SUCRA comparing early functional outcome and composite complications (dislocation, intra-operative fracture, wound complication, and nerve injury) found DAA was the best approach followed by DSA/SuperPath. CONCLUSION DSA/SuperPath had better earlier functional outcome than PA, but still could not overcome the result of DAA. This technique might be the other preferred option with acceptable complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ste完成签到,获得积分10
刚刚
刚刚
3秒前
bkagyin应助MOLLY采纳,获得10
3秒前
专注的代天完成签到,获得积分10
3秒前
地球发布了新的文献求助10
3秒前
kkkkkkk发布了新的文献求助10
4秒前
qing发布了新的文献求助10
6秒前
隐形曼青应助Tracy采纳,获得10
7秒前
9秒前
9秒前
不安的成协完成签到,获得积分10
9秒前
噜噜噜完成签到,获得积分10
9秒前
11秒前
自然醒应助风云鱼采纳,获得10
12秒前
12秒前
shenmin发布了新的文献求助10
12秒前
13秒前
地球发布了新的文献求助10
14秒前
Kashing发布了新的文献求助20
15秒前
自然醒应助静默采纳,获得10
15秒前
15秒前
17秒前
蛋黄酥完成签到,获得积分20
17秒前
17秒前
18秒前
地球发布了新的文献求助10
18秒前
烟花应助kkkkkkk采纳,获得10
19秒前
19秒前
20秒前
20秒前
cc发布了新的文献求助10
21秒前
地球发布了新的文献求助10
22秒前
22秒前
NexusExplorer应助zjcomposite采纳,获得10
22秒前
22秒前
147发布了新的文献求助10
23秒前
25秒前
氨气发布了新的文献求助10
25秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6517235
求助须知:如何正确求助?哪些是违规求助? 8310298
关于积分的说明 17764830
捐赠科研通 5619592
什么是DOI,文献DOI怎么找? 2925899
邀请新用户注册赠送积分活动 1902725
关于科研通互助平台的介绍 1763767